News & Views
GSK issues swine flu vaccine update
Apr 01 2010
In an update regarding the virus, GSK said it is working closely with governments from around the world to offer bespoke programmes for dealing with the issue.
"Pandemics by their nature are unpredictable and we recognise that governments needs are changing," it explained.
Earlier this year, the pharmaceutical giant said it started delivering two doses of the vaccine, but found high immune responses after lab testing to one of the medicines.
According to the firm, it continues to collect data regarding clinical trial programmes in relation to H1N1 medications and recently amended an existing agreement with Japan to deliver 68 per cent of ordered units.
The World Health Organization note laboratory-confirmed testing has revealed over 200 countries are experiencing swine flu cases.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark